Author: Gao, Shun-Cai et al. Anesthesiology. August 2025. doi:10.1097/ALN.0000000000005711 This randomized trial evaluated whether intraoperative urine-guided hydration could reduce acute kidney injury (AKI) in patients undergoing cytoreductive surgery (CRS) and cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei. A total of 168 adults were randomized to either urine-guided hydration (targeting ≥3 mL·kg⁻¹·h⁻¹ or ≥200 mL·h⁻¹) […]
Read MoreWe’re excited to announce the formation of a new anesthesia group in Riverdale, GA, located just 10 minutes from the Atlanta Airport. We’re seeking dedicated CRNAs to join our collaborative care team, which will include 4 full-time CRNAs and 2 anesthesiologists managing 4 operating rooms. This is a 25% independent practice and doing own blocks! […]
Read MoreIf you’re an anesthesiologist searching for a balanced lifestyle and rewarding work, you’ll want to check out this opportunity. Our all-anesthesiologist group is seeking a dedicated team member to join our collaborative practice. Position Highlights: Zero Call for 3 Weeks: Enjoy three weeks of no call duty, followed by one week of call. Even during […]
Read MoreAuthor: Sophie Eydis Becker’s ASC Review With more procedures moving to the ASC setting, anesthesia leaders see opportunities to improve recovery and efficiency — but warn that safety readiness and broken reimbursement models could slow momentum. On July 15, CMS approved more than 200 additional procedures for the ASC setting, intensifying the need for anesthesia teams to […]
Read MoreAuthor: Sekela, Michael E. et al. Anesthesiology. August 2025. doi:10.1097/ALN.0000000000005716 This Phase III, double-blind, non-inferiority trial (ReCePI) evaluated pathogen-reduced red blood cells (treated with amustaline/glutathione) compared to conventional transfusions in patients undergoing cardiac or thoracic-aorta surgery at high risk for red cell transfusion. The primary endpoint was the incidence of acute kidney injury (AKI) within […]
Read More